{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:04:24Z","timestamp":1782407064868,"version":"3.54.5"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225575","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T19:49:58Z","timestamp":1574365798000},"page":"e0225575","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-0171","authenticated-orcid":true,"given":"Henry Dilonga","family":"Meriki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kukwah Anthony","family":"Tufon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian Nota","family":"Anong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal Nji","family":"Atanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Ane","family":"Anyangwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelis","family":"Cho-Ngwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Nkuo-Akenji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"pone.0225575.ref001","unstructured":"World Health Organisation. HIV\/AIDS: Key facts. In: World Health Organisation [Internet]. 2018 [cited 20 Aug 2018]. Available: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"key":"pone.0225575.ref002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/fvl.12.4","article-title":"Genetic diversity and molecular epidemiology of HIV transmission","volume":"7","author":"E Castro-Nallar","year":"2012","journal-title":"Future Virol"},{"key":"pone.0225575.ref003","first-page":"e0205446","volume-title":"PLoS One.","author":"DA Arimide","year":"2018"},{"key":"pone.0225575.ref004","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1128\/JVI.01225-12","article-title":"HIV Populations Are Large and Accumulate High Genetic Diversity in a Nonlinear Fashion","volume":"87","author":"F Maldarelli","year":"2013","journal-title":"J Virol."},{"key":"pone.0225575.ref005","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/cid\/ciq248","article-title":"Update on human immunodeficiency virus (HIV)-2 infection","volume":"52","author":"OT Campbell-Yesufu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pone.0225575.ref006","first-page":"287","article-title":"Impact of genetic diversity of HIV-1 on diagnosis, antiretroviral therapy & vaccine development","author":"RB Lal","year":"2005","journal-title":"Indian Journal of Medical Research"},{"key":"pone.0225575.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a007187","article-title":"The HIV-1 epidemic: Low- to middle-income countries","volume":"2","author":"Y Shao","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"pone.0225575.ref008","doi-asserted-by":"crossref","first-page":"55d","DOI":"10.1126\/science.288.5463.55d","article-title":"HIV-1 Nomenclature Proposal","volume":"288","author":"DL Robertson","year":"2000","journal-title":"Science"},{"key":"pone.0225575.ref009","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/088922201750236951","article-title":"Evidence of Two Distinct Subsubtypes within the HIV-1 Subtype A Radiation","volume":"17","author":"F Gao","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225575.ref010","first-page":"83","article-title":"Update on HIV-1 diversity in Africa: A decade in review","volume":"14","author":"RW Lihana","year":"2012","journal-title":"AIDS Rev"},{"key":"pone.0225575.ref011","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-6405-9-5","article-title":"HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004\u20132005","volume":"9","author":"M Akrim","year":"2012","journal-title":"AIDS Res Ther"},{"key":"pone.0225575.ref012","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/aid.2006.22.367","article-title":"High diversity of HIV type 1 in Algeria","volume":"22","author":"S Bouzeghoub","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225575.ref013","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/315167","article-title":"Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt","volume":"181","author":"NM El Sayed","year":"2000","journal-title":"J Infect Dis"},{"key":"pone.0225575.ref014","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/JVI.02005-10","article-title":"Confirmation of Putative HIV-1 Group P in Cameroon","volume":"85","author":"A Vallari","year":"2011","journal-title":"J Virol"},{"key":"pone.0225575.ref015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/aid.2009.0178","article-title":"Four New HIV-1 Group N Isolates from Cameroon: Prevalence Continues to Be Low","volume":"26","author":"A Vallari","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225575.ref016","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2016","article-title":"A new human immunodeficiency virus derived from gorillas","volume":"15","author":"J-C Plantier","year":"2009","journal-title":"Nat Med."},{"key":"pone.0225575.ref017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-4690-7-39","article-title":"HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics?","volume":"7","author":"JK Carr","year":"2010","journal-title":"Retrovirology"},{"key":"pone.0225575.ref018","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/00126334-200412150-00019","article-title":"Genetic diversity of HIV type 1 in rural eastern Cameroon","volume":"37","author":"N Ndembi","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0225575.ref019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/QAI.0b013e31818d5a40","article-title":"High frequency of HIV-1 dual infections among HIV-positive individuals in Cameroon, West Central Africa","volume":"50","author":"RLR Powell","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"pone.0225575.ref020","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/088922203771881284","article-title":"Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity","volume":"19","author":"P Zhong","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225575.ref021","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.coviro.2012.08.006","article-title":"Are subtype differences important in HIV drug resistance?","volume":"2","author":"RJ Lessells","year":"2012","journal-title":"Curr Opin Virol."},{"key":"pone.0225575.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118145","article-title":"High prevalence of the k65r mutation in hiv-1 subtype c infected patients failing tenofovir-based first-line regimens in south africa","volume":"10","author":"L Skhosana","year":"2015","journal-title":"PLoS One"},{"key":"pone.0225575.ref023","first-page":"299","article-title":"HIV drug resistance patterns at the epicentre of the HIV-1 epidemic in Kwazulu-Natal, South Africa 2003\u20132013 [Internet]","author":"P Kiepiela","year":"2014","journal-title":"Journal of AIDS and Clinical Research"},{"key":"pone.0225575.ref024","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3851\/IMP1906","article-title":"Etravirine and rilpivirine resistance in HIV-1 subtype CRF01-AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens","volume":"16","author":"T. Bunupuradah","year":"2011","journal-title":"Antivir Ther"},{"key":"pone.0225575.ref025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.meegid.2007.02.001","article-title":"Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy","volume":"7","author":"A Carvajal-Rodr\u00edguez","year":"2007","journal-title":"Infect Genet Evol"},{"key":"pone.0225575.ref026","doi-asserted-by":"crossref","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). 90-90-90 An ambitious treatment target to help end the AIDS epidemic [Internet]. http:\/\/www.Unaids.Org\/Sites\/Default\/Files\/Media_Asset\/90-90-90_En_0.Pdf. 2014. doi: 10.7448\/IAS.16.4.18751","DOI":"10.7448\/IAS.16.4.18751"},{"key":"pone.0225575.ref027","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-4690-5-13","article-title":"Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature","volume":"5","author":"ME Falagas","year":"2008","journal-title":"Retrovirology"},{"key":"pone.0225575.ref028","first-page":"574656","article-title":"Determinants of Adherence to Antiretroviral Therapy among HIV-Infected Patients in Africa.","volume":"2012","author":"AA Reda","year":"2012","journal-title":"AIDS Res Treat"},{"key":"pone.0225575.ref029","article-title":"MEGA X: Molecular evolutionary genetics analysis across computing platforms","author":"S Kumar","year":"2018","journal-title":"Mol Biol Evol"},{"key":"pone.0225575.ref030","unstructured":"WHO, CDC, TheGlobalFund. HIV Drug Resistance Report 2017 Trends Quality Action [Internet]. HIV Drug Resistance Report 2017 Trends Quality Action. 2017. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255896\/9789241512831-eng.pdf?sequence=1"},{"key":"pone.0225575.ref031","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1743-422X-8-185","article-title":"Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon","volume":"8","author":"V Ragupathy","year":"2011","journal-title":"Virol J."},{"key":"pone.0225575.ref032","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1742-4690-9-S2-P158","article-title":"Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug na\u00efve in Limbe, Cameroon","volume":"9","author":"L Agyingi","year":"2012","journal-title":"Retrovirology."},{"key":"pone.0225575.ref033","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jmv.23244","article-title":"Characterization of drug resistance mutations in na??ve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon","volume":"84","author":"L Ceccarelli","year":"2012","journal-title":"J Med Virol"},{"key":"pone.0225575.ref034","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/aid.2006.22.812","article-title":"HIV genetic diversity in Cameroon: possible public health importance","volume":"22","author":"CB Ndongmo","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225575.ref035","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14095-4","article-title":"Gag P2\/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02-AG- and non-CRF02-AG-infected patients in Yaound\u00e9, Cameroon","volume":"7","author":"G Teto","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0225575.ref036","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/JCM.00634-17","article-title":"Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients","volume":"55","author":"AJ Nanfack","year":"2017","journal-title":"J Clin Microbiol"},{"key":"pone.0225575.ref037","article-title":"Observed HIV drug resistance associated mutations amongst na\u00efve immunocompetent children in Yaound\u00e9, Cameroon","author":"G Mondinde Ikomey","year":"2017"},{"key":"pone.0225575.ref038","first-page":"390","article-title":"Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil","volume":"11","author":"MS Medeiros","year":"2007","journal-title":"Brazilian J Infect Dis"},{"key":"pone.0225575.ref039","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.qai.0000397379.23943.e1","article-title":"Population Level Drug Resistance Mutations in HIV Type 1 Protease and Reverse Transcriptase in Cameroon: 1995 to 2010 Review","volume":"56","author":"JN Torimiro","year":"2011","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"pone.0225575.ref040","first-page":"547","article-title":"Improving Viral Protease Inhibitors to Counter Drug Resistance. Trends Microbiol.","volume":"24","author":"N Kurt Yilmaz","year":"2016","journal-title":"NIH Public Access"},{"key":"pone.0225575.ref041","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2105-15-72","article-title":"Natural polymorphisms and unusual mutations in HIV-1 protease with potential antiretroviral resistance: a bioinformatic analysis","volume":"15","author":"C Mata-Mungu\u00eda","year":"2014","journal-title":"BMC Bioinformatics."},{"key":"pone.0225575.ref042","doi-asserted-by":"crossref","first-page":"a012526","DOI":"10.1101\/cshperspect.a012526","article-title":"HIV Pathogenesis: Dynamics and Genetics of Viral Populations and Infected Cells","volume":"3","author":"J Coffin","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"pone.0225575.ref043","first-page":"S1","article-title":"Genetic barrier to antiretroviral drug-resistance. Focus on raltegravir, the first integrase inhibitor","volume":"40","author":"C. Delaugerre","year":"2010","journal-title":"M\u00e9decine Mal Infect"},{"key":"pone.0225575.ref044","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1089\/aid.2007.0072","article-title":"HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, C\u00f4te d\u2019Ivoire: A 4-year survey, 2002\u20132006","volume":"23","author":"Toni T d\u2019Aquin","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"pone.0225575.ref045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.19.1.20798","article-title":"Treatment failure and drug resistance in hiv-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya","volume":"19","author":"K Brooks","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"pone.0225575.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.16.1.18004","article-title":"Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months\u2019 antiretroviral therapy experience in Cameroon.","volume":"16","author":"AF Aghokeng","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"pone.0225575.ref047","doi-asserted-by":"crossref","first-page":"e0181997","DOI":"10.1371\/journal.pone.0181997","article-title":"HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.","volume":"12","author":"B Lin","year":"2017","journal-title":"PLoS One. Public Library of Science"},{"key":"pone.0225575.ref048","doi-asserted-by":"crossref","first-page":"e0189460","DOI":"10.1371\/journal.pone.0189460","article-title":"Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania","volume":"12","author":"SK Semvua","year":"2017","journal-title":"PLoS One. Public Library of Science"},{"key":"pone.0225575.ref049","doi-asserted-by":"crossref","first-page":"e0174613","DOI":"10.1371\/journal.pone.0174613","article-title":"Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression","volume":"12","author":"KJ Siefried","year":"2017","journal-title":"PLoS One."},{"key":"pone.0225575.ref050","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral Therapy","volume":"38","author":"J-J Parienti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"pone.0225575.ref051","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10461-014-0724-0","article-title":"Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States","volume":"18","author":"JS Lehman","year":"2014","journal-title":"AIDS Behav."},{"key":"pone.0225575.ref052","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2049-9957-3-5","article-title":"Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon","volume":"3","author":"HD Meriki","year":"2014","journal-title":"Infect Dis poverty"},{"key":"pone.0225575.ref053","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jix544","article-title":"Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013\u20132014","volume":"216","author":"RA Silverman","year":"2017","journal-title":"J Infect Dis"},{"key":"pone.0225575.ref054","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/135965350901400317","article-title":"Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-1infected patients","volume":"14","author":"A Soria","year":"2009","journal-title":"Antivir Ther"},{"key":"pone.0225575.ref055","doi-asserted-by":"crossref","first-page":"1004439","DOI":"10.1371\/journal.pgen.1004439","article-title":"Recombination Accelerates Adaptation on a Large-Scale Empirical Fitness Landscape in HIV-1","volume":"10","author":"D Moradigaravand","year":"2014","journal-title":"PLoS Genet"},{"key":"pone.0225575.ref056","article-title":"HIV-1 Genetic Variability and Clinical Implications.","author":"MM Santoro","year":"2013","journal-title":"ISRN Microbiol"},{"key":"pone.0225575.ref057","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/AAC.06079-11","article-title":"Effect of natural polymorphisms in the HIV-1 CRF02-AG protease on protease inhibitor hypersusceptibility","volume":"56","author":"AFA Santos","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0225575.ref058","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/v2020503","article-title":"HIV genetic diversity and drug resistance.","volume":"2","author":"AF Santos","year":"2010","journal-title":"Viruses"},{"key":"pone.0225575.ref059","doi-asserted-by":"crossref","first-page":"e62408","DOI":"10.1371\/journal.pone.0062408","article-title":"Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment","volume":"8","author":"H Xing","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:04:33Z","timestamp":1665075873000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225575"}},"subtitle":[],"editor":[{"given":"Jason","family":"Blackard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225575","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}